Sanjay S. Shukla
2020
In 2020, Sanjay S. Shukla earned a total compensation of $1.1M as President and CEO at aTYR PHARMA, a 63% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $223,369 |
|---|---|
| Option Awards | $381,811 |
| Salary | $470,250 |
| Other | $8,427 |
| Total | $1,083,857 |
Shukla received $470.3K in salary, accounting for 43% of the total pay in 2020.
Shukla also received $223.4K in non-equity incentive plan, $381.8K in option awards and $8.4K in other compensation.
Rankings
In 2020, Sanjay S. Shukla's compensation ranked 8,299th out of 13,090 executives tracked by ExecPay. In other words, Shukla earned more than 36.6% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 8,299 out of 13,090 | 37th |
Division Manufacturing | 3,521 out of 5,621 | 37th |
Major group Chemicals And Allied Products | 1,423 out of 2,254 | 37th |
Industry group Drugs | 1,239 out of 1,954 | 37th |
Industry Biological Products, Except Diagnostic Substances | 294 out of 411 | 29th |
Source: SEC filing on March 23, 2021.
Shukla's colleagues
We found two more compensation records of executives who worked with Sanjay S. Shukla at aTYR PHARMA in 2020.
News
aTYR PHARMA CEO Sanjay Shukla's 2023 pay falls 46% to $1.3M
April 5, 2024
aTYR PHARMA CEO Sanjay Shukla's 2021 pay jumps 75% to $1.9M
March 22, 2022
aTYR PHARMA CEO Sanjay Shukla's 2020 pay jumps 63% to $1.1M
March 23, 2021
aTYR PHARMA CEO Sanjay Shukla's 2019 pay falls 52% to $664K
April 2, 2020
aTYR PHARMA CEO Sanjay Shukla's 2018 pay falls 36% to $1.4M
March 28, 2019